Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Current nucleic acid amplification methods to detect Mycobacterium tuberculosis are complex, labor-intensive, and technically challenging. We developed and performed the first analysis of the Cepheid Gene Xpert System's MTB/RIF assay, an integrated hands-free sputum-processing and real-time PCR system with rapid on-demand, near-patient technology, to simultaneously detect M. tuberculosis and rifampin resistance. Analytic tests of M. tuberculosis DNA demonstrated a limit of detection (LOD) of 4.5 genomes per reaction. Studies using sputum spiked with known numbers of M. tuberculosis CFU predicted a clinical LOD of 131 CFU/ml. Killing studies showed that the assay's buffer decreased M. tuberculosis viability by at least 8 logs, substantially reducing biohazards. Tests of 23 different commonly occurring rifampin resistance mutations demonstrated that all 23 (100%) would be identified as rifampin resistant. An analysis of 20 nontuberculosis mycobacteria species confirmed high assay specificity. A small clinical validation study of 107 clinical sputum samples from suspected tuberculosis cases in Vietnam detected 29/29 (100%) smear-positive culture-positive cases and 33/39 (84.6%) or 38/53 (71.7%) smear-negative culture-positive cases, as determined by growth on solid medium or on both solid and liquid media, respectively. M. tuberculosis was not detected in 25/25 (100%) of the culture-negative samples. A study of 64 smear-positive culture-positive sputa from retreatment tuberculosis cases in Uganda detected 63/64 (98.4%) culture-positive cases and 9/9 (100%) cases of rifampin resistance. Rifampin resistance was excluded in 54/55 (98.2%) susceptible cases. Specificity rose to 100% after correcting for a conventional susceptibility test error. In conclusion, this highly sensitive and simple-to-use system can detect M. tuberculosis directly from sputum in less than 2 h.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have shown that Xpert does not cross‐react with other mycobacterial species (Blakemore 2010; Helb 2010).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Helb 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This represents a substantial reduction in diagnostic delay, thereby permitting real-time decision making and planning of treatment (5).”
From Xpert MTB/RIF for Rapid Diagnosis of Tuberculous Lymphadenitis from Fine-Needle-Aspiration Biopsy Specimens (2011) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies reported 98–100% agreement in detection of rifampicin resistance strains using the Xpert test and phenotypic drug susceptibility test [13,14,18,26].”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Such cases (Xpert-positive but culture-negative) are likely to be true TB positives as corroborated by the high specificity [14,18] and by the fact that the procedure is less prone to contamination due to the closed reaction chamber (real-time PCR technology) of Xpert.”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“In agreement with other studies [9,18,22], Xpert has a higher sensitivity than smear microscopy.”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Two-sided confidence intervals for the single proportion: comparison of seven methods
Newcombe, R. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e · Cited by 5,107
Probable Inference, the Law of Succession, and Statistical Inference
Wilson, E. B. (1927) · Journal of the American Statistical Association · doi:10.1080/01621459.1927.10502953 · Cited by 4,476
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. A. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,072
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A., & Berman, S. M. (2007) · Clinical Infectious Diseases · doi:10.1086/511430 · Cited by 1,973
The association for the advancement of medical instrumentation
(1974) · Ultrasound in Medicine & Biology · doi:10.1016/0301-5629(74)90035-0 · Cited by 1,031
Anti-tuberculosis drug resistance in the world
Wilkinson, D. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90766-0 · Cited by 700
Molecular Detection of Antimicrobial Resistance
Fluit, A. C., Visser, M. R., & Schmitz, F.-J. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.836-871.2001 · Cited by 525 · cited 1×
“tuberculosis detection (15), this assay was too complex and too prone to operator errors, sample cross-contamination, and biohazards for rapid near-patient use.”
BackgroundEspinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baéz, J., Kochi, A., Dye, C., & Raviglione, M. C. (2000) · JAMA · doi:10.1001/jama.283.19.2537 · Cited by 507 · cited 3×
“Truly rapid results for drug susceptibility tests are particularly important in the management of drug-resistant tuberculosis (13).”
BackgroundMicroscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TB
Moore, D. A. J., Evans, C. A. W., Gilman, R. H., Caviedes, L., Coronel, J., Vivar, A., Sanchez, E., Piñedo, Y., Saravia, J. C., Salazar, C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055524 · Cited by 468
Cited by
Items 901–940 of 940
Aich, I., Sau, B., Acharya, S., Ghosh, P., Ghosh, S., SenGupta, M., Chatterjee, M., & Mal, S. (2026) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20260628
Sabella-Jiménez, V. L., Sabella‐Jiménez, V., Estupiñán-Bohorquez, A. F., & Acosta-Reyes, J. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-105136
Ou, X., Zhao, B., Xia, H., Bao, X., Xu, D., Ma, Q., Xu, Y., Li, J., Shi, W., Li, F., et al. (2026) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-026-04858-5
Mycobacterium tuberculosis as a model system
Barnard, E., Elgrail, M. M., Fay, A., Ozakman, Y., & Glickman, M. S. (2026) · Journal of Bacteriology · doi:10.1128/jb.00609-25 · Cited by 1
“Amplification and detection occur within a self-contained cartridge, allowing automated sample processing and real-time monitoring of PCR product accumulation (142).”
Moyens modernes du diagnostic de la tuberculose pulmonaire
Khéchine, A. E. (2011) · theses.fr (ABES) · doi:10.70675/6107f9e1z551fz49f1z92e1zefb9526b2286
Ratovonirina, N. H. (2017) · theses.fr (ABES) · doi:10.70675/7b2da415zfc78z471bzb474zca24256406a7 · Cited by 3
“…(D'Amato et al., 1995), par la PCR en temps réel comme pour le cas du Xpert MTB/RIF(§ I.6.4.2-c) (Blakemore et al., 2010; Broccolo et al., 2003; Helb et al., 2010), ou aussi par la LAMP-PCR (Loop-mediated isothermal amplification) (Boehme et al., 2007; Cao et al., 2015) permettant la…”
BackgroundInfluentialIdentification and characterization of allosteric sites of UMP kinase
Walter, P. (2019) · theses.fr (ABES) · doi:10.70675/099ed39czcc5fz47e4zb763z70c1a3804b90
Identification et caractérisation de HadD, une nouvelle déshydratase du système FAS-II mycobactérien
Lefebvre, C. (2018) · theses.fr (ABES) · doi:10.70675/c28dae92zd4a2z463bzb425z8c14e7eb2856
Maafi, K., Nafi, I., Laariche, F., Nabil, M., Abidar, H., Souly, K., & Aboudkhil, S. (2026) · Natural Built Social Environment Health · doi:10.63095/nbseh.26.455534
Son, E.-S., Lee, J.-I., Kim, J.-H., Cho, E., Mee-Kyung, K., So, S., & Lee, J. S. (2026) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2026.100616
“This gap in detection highlights the urgent need for improved diagnostic capabilities [4].”
Key operational challenges at a programmatic level to achieve optimal use of the GeneXpert platform
Martin, I. C., Hakizayezu, F., Kamanzi, E., Habimana, Y. M., Migambi, P., de Jong, B. C., Rigouts, L., & Ngabonziza, J.-C. S. (2026) · IJTLD OPEN · doi:10.5588/ijtldopen.25.0630
Mahamat, A. O., Abderrazzack, A. F., Ngandolo, R. B. N., Abakar, H. T., Oumarou, A., Frederic, D., Didi, L., Adam, O. Y., Ahmat, A. M., Doungous, D. M., et al. (2026) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2026.146015
Rudeeaneksin, J., Phetsuksiri, B., Srisungngam, S., Bunchoo, S., Bhakdeenuan, P., & Klayut, W. (2026) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946202668040
“In contrast, molecular or genotypic DST provides rapid results for the early detection of DR-TB by simultaneously detecting multiple frequent mutations that confer drug resistance 18 - 20 .”
Kassimi, S. E., Eddabra, R., Belkadi, B., Filali‐Maltouf, A., & Benhassou, H. A. (2026) · Diagnostics · doi:10.3390/diagnostics16132133 · Cited by 1
“Rifampicin resistance detection was similarly robust, with sensitivity and specificity greater than 95% compared with phenotypic drug susceptibility testing (DST) [9,21].”
Cano-Fernández, M., Barrado, L., Bermúdez-Marval, H., Pineda, M. C., de la Torre, I. D., Domingo, D., Hernández, S., Garcia-Martinez, J., López-Roa, P., Loras-Gallego, C., et al. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00175-26
Optimising tongue-swab Xpert MTB/RIF Ultra testing as a diagnostic system
Rojas-Ponce, G. (2026) · The Lancet Microbe · doi:10.1016/j.lanmic.2026.101498
Ambient-Temperature Extraction-Free One-Pot CRISPR Detection of Mycobacterium tuberculosisPreprint
Liao, J., Su, Y., & Jiang, F. (2026) · medRxiv · doi:10.64898/2026.07.21.26358604
Gitari, J. W., Koch, A. S., Kigondu, E., Warner, D. F., & Mason, M. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.08.743631
“The control (GeneXpert buffer which is used as a proxy to compromise the cell envelope) showed loss of GFP within the first hour of exposure and uptake of PI to indicate cell membrane permeabilization and cell death as reported in a related study (Helb et al., 2010).”
Nwafor, I. E., Ufoaroh, C. U., Ezeanolue, B. C., Afiadigwe, E. E., Obasikene, G., Menkiti, F. E., Nwafor, E. N., & Nduka, C. C. (2026) · Journal of the Pan African Thoracic Society · doi:10.25259/jpats_12_2026
Mukherjee, J. S., Ndayizigye, M., Lee, C., Gilmore, M., Benali, S., Maama, L., & Andom, A. T. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1941743
“GeneXpert— a molecular test that simultaneously detects the presence of TB as well as the mutation that confers rifampicin resistance — became available starting in 2011 as a programmatic diagnostic tool (8, 9) and demonstrated superior sensitivity compared to smear microscopy.”
Rapid Molecular Diagnostics of Tuberculosis: What Do We Have, What Do We Need?
Luukinen, B. V. (2026) · Pulmonary Medicine · doi:10.1155/pm/9947140
Sharma, S., Gupta, P., Singhal, A., Kour, I., Kaur, H., Gupta, V., & Singhal, L. (2026) · Cureus · doi:10.7759/cureus.117122
Eze, C. G. (2026) · INTERNATIONAL JOURNAL OF HEALTH AND PHARMACEUTICAL RESEARCH · doi:10.56201/ijhpr.vol.11.no1.2026.pg84.92
Pandita, I., Tayade, S. N., Shirodker, T. G., & Khanduri, A. (2026) · World Journal of Current Medical and Pharmaceutical Research · doi:10.37022/wjcmpr.v8i3.433
An Updated Bibliometric Analysis of Tuberculosis Research in ASEAN Countries: 2000–2024
Netthong, R., Khumsikiew, J., Donsamak, S., & Yingngam, B. (2024) · Interprofessional Journal of Health Sciences
П.Х., Г. З. А. Н., & Gaziev, Z. A. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7357576
Patwegar, S., Kulkarni, D. V., Karekar, B., Nimale, D. A., Sabne, S., Singh, A., Sahai, S., & Mehrotra, N. (2026) · Medico Research Chronicles
Ding, C., Ji, Z., Li, X., Fu, H., 許昭諭, Chen, H., Sheng, C., Zhang, C., Sun, W., & Xu, K. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.02103-26
“Real-time amplification and melting curve analysis enable quantitative detection (limit of detection: 13.34 CFU/mL; 95% CI, 11.71–16.47), (15) which represents an approximately 10-fold improvement over that of Xpert/RIF (131 CFU/mL) (10).”
InfluentialTuberculosis pediátrica en niños mexicanos: Estudio retrospectivo de 100 pacientes
RIVERA, O. 5. T., NOYOLA, E. G. V., Mendizábal, R. J. E., & Barrera, E. R. (2022) · Repositorio del Tecnológico de Monterrey (Tecnológico de Monterrey)
Worku, G., Gumi, B., Girma, M., Mohammedbirhan, B., Diriba, G., Seid, G., Getu, M., Amare, M., Sinshaw, W., Ashagre, W., et al. (2022) · doi:10.3389/fpubh.2022.942618.s001
Guan, Z., Han, X., Huang, W., Wang, X., Wang, H., & Fan, Y. (2023) · doi:10.3389/fcimb.2023.1128337.s005
Iem, V., Chittamany, P., Suthepmany, S., Siphanthong, S., Somphavong, S., Kontogianni, K., Dodd, J., Khan, J. A. M., Dominguez, J., Wingfield, T., et al. (2022) · doi:10.1371/journal.pgph.0000116.r003
Worku, G., Gumi, B., Girma, M., Mohammedbirhan, B., Diriba, G., Seid, G., Getu, M., Amare, M., Sinshaw, W., Ashagre, W., et al. (2022) · doi:10.3389/fpubh.2022.942618.s003
Hall, G. S., Mark, K., Tuohy, M. J., & Sholtis, M. (2011) · Molecular Microbiology · doi:10.1128/9781555816834.ch6
Roskos, K. (2013) · Scholarship - Claremont (Claremont Colleges) · doi:10.5642/kgitd/2
Metadata
- Authors
- Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., Safi, H., Blakemore, R., Lan, N. T. N., Jones-López, E. C., Levi, M., Burday, M., Ayakaka, I., Mugerwa, R. D., McMillan, B., Winn-Deen, E., Christel, L., Dailey, P., Perkins, M. D., Persing, D. H., & Alland, D.
- Affiliations
- Rutgers New Jersey Medical School (US)
- Cepheid (United States) (US)
- Department of Medicine, New Jersey Medical School, University of Medicine and Dentistry, New Jersey, Newark, New Jersey
- FIND (CH)
- Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
- Montefiore Medical Center (US)
- Makerere University (UG)
- ORCID
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2010-01
- Volume
- 48
- Issue
- 1
- Pages
- 229-237
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC2812290
- OpenAlex
- W2112022845
- Cited by
- 914
- References
- 59
- Citations by year
- 2026: 29 · 2025: 38 · 2024: 35 · 2023: 33 · 2022: 36 · 2021: 45 · 2020: 65 · 2019: 55 · 2018: 61 · 2017: 62 · 2016: 63 · 2015: 62 · 2014: 74 · 2013: 71 · 2012: 62
- FWCI
- 41.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R41AI052523, R42AI052523, R42-AI52523, R41-AI52523)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- Mycobacterium tuberculosis detection, rifampicin resistance, Xpert MTB/RIF, point-of-care testing, real-time PCR, sputum, detection limit, nontuberculous mycobacteria, retreatment tuberculosis, tuberculosis diagnosis
- MeSH terms
- Adolescent, Adult, Aged, Antitubercular Agents, Bacteriological Techniques, Female, Humans, Male, Middle Aged, Mycobacterium tuberculosis, Rifampin, Sensitivity and Specificity, Sputum, Tuberculosis, Uganda, Vietnam, Polymerase Chain Reaction, Point-of-Care Systems, Drug Resistance, Bacterial, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.